With over 20 years of experience in the business and policy of health care, Sarah leads the strategic operations of the Institute for Clinical and Economic Review, a leading non-profit health policy research organization, as Executive Vice President and Chief Operating Officer.

Prior to joining ICER, Sarah spent six years in the corporate communications and investor relations department at a commercial-stage biopharmaceutical company, and several years with a health care communications firm. Sarah began her career in clinical research at Beth Israel Deaconess Medical Center in Boston.

Sarah holds a Master of Public Policy degree with a concentration in health policy from the Heller School at Brandeis University and received a bachelor’s degree in biological sciences from Smith College. Sarah speaks frequently at national conferences on the topics of prescription drug pricing policy, comparative effectiveness research, and value-based health care.